Myofascial Pelvic Pain Syndrome (MPPS)
Conditions
Interventions
High-frequency Group (Observation Group):None
Low-frequency Group (Control Group):None
Sponsors
Jiaxing Maternity and Child Health Care Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for myofascial pelvic pain syndrome (MPPS) with the following clinical features: Regional pain: mainly deep dull pain, distending pain or stabbing pain in the vulva, vagina, rectum, etc. Function - related symptom clusters: combined with lower urinary tract symptoms (such as frequent urination, urgency, etc.), bowel dysfunction or dyspareunia. Specific signs: myofascial trigger points can be palpated during physical examination. 2. Patients diagnosed and treated in our hospital from April 2021 to December 2025. 3. Aged 18 - 60 years old, with a disease duration of more than 3 months. 4. Receive a full - course standardized manual release treatment (treatment cycle >= 4 weeks), with a clear frequency of 2 - 3 times a week or less than 2 times a week. 5. Simultaneously receive unified combined adjuvant therapy (electrical stimulation, biofeedback and home - based training) with good compliance. 6. Have complete clinical data, with a missing rate of relevant records <= 10%. 7. Have no severe systemic diseases or mental diseases and be able to cooperate in completing the assessment.
Exclusion criteria
Exclusion criteria: 1. Co - existing pelvic organic diseases (such as uterine fibroids, endometriosis), urinary system diseases, anorectal diseases or lumbosacral joint diseases that affect pain assessment. 2. Poor treatment compliance, failure to complete the corresponding frequency of treatment as prescribed, or unauthorized interruption/change of the treatment plan. 3. Co - existing severe systemic diseases of the heart, liver, kidneys, endocrine system, etc., or mental diseases, and unable to cooperate with the assessment. 4. A large amount of clinical data is missing (missing rate > 10%), and data extraction and analysis cannot be completed. 5. Failure to complete the follow - up after treatment, and unable to obtain complete information on treatment efficacy or recurrence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Pain Score;Number of Pelvic Floor Trigger Points;VAS Score of Trigger Points;Muscle Strength (Type I/II);Resting Muscle Tension; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence Rate;Incidence of Adverse Reactions; | — |
Countries
China
Contacts
Public ContactWei Changna
Jiaxing Maternity and Child Health Care Hospital
Outcome results
None listed